Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Sigilon Therapeutics

Sigilon Therapeutics

Sigilon Therapeutics is a Cambridge, Massachusetts-based biotechnology company founded by Omid Veiseh.

Sigilon Therapeutics focuses on therapeutics and develops functional cures for patients with a wide range of chronic diseases. Its Shielded Living Therapeutics platform combines advanced cell engineering with innovations in biocompatible materials.

Timeline

March 17, 2020
Sigilon Therapeutics raises a $80,000,000 series B round.
April 2018
Sigilon Therapeutics raises a $13,100,000 series A round from Eli Lilly and Company.
2015
Sigilon Therapeutics was founded by Omid Veiseh.

Funding Rounds

Patents

Further Resources

Title
Author
Link
Type
Date

References

Golden logo
By using this site, you agree to our Terms & Conditions.